{"transactions":[{"id":4632910,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-10-02T00:04:09.000Z","date":"2026-09-29","kind":"sale","planned":false,"acquired":false,"shares":27370,"price":9.46,"value":258920.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The prices sold ranged from $9.445 to $9.48 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":52731,"source":{"system":"sec-edgar","filing":"0001796536-26-000010","document":"form4-10012026_081003.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000179653626000010/form4-10012026_081003.xml","form_type":"4"}},{"id":4627552,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":59538,"kind":"person","name":"Salovey Peter","position":1,"cik":"0002088468","reported_name":"Salovey Peter","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-28T20:10:19.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":28330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":55096,"source":{"system":"sec-edgar","filing":"0002088468-26-000006","document":"form4-09282026_040912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2088468/000208846826000006/form4-09282026_040912.xml","form_type":"4"}},{"id":4627553,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":43287,"kind":"person","name":"Heyman Tomas J.","position":1,"cik":"0001814673","reported_name":"Heyman Tomas J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-28T20:10:15.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":20986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":53720,"source":{"system":"sec-edgar","filing":"0001814673-26-000005","document":"form4-09282026_040909.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1814673/000181467326000005/form4-09282026_040909.xml","form_type":"4"}},{"id":4627554,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":59537,"kind":"person","name":"Mao Li","position":1,"cik":"0002106809","reported_name":"Mao Li","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-28T20:10:13.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":20986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":65316,"source":{"system":"sec-edgar","filing":"0002106809-26-000005","document":"form4-09282026_040908.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2106809/000210680926000005/form4-09282026_040908.xml","form_type":"4"}},{"id":4627555,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":33365,"kind":"person","name":"Casey Patrick John","position":1,"cik":"0002068365","reported_name":"Casey Patrick John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-28T20:10:11.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":20986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":69590,"source":{"system":"sec-edgar","filing":"0002068365-26-000009","document":"form4-09282026_040906.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2068365/000206836526000009/form4-09282026_040906.xml","form_type":"4"}},{"id":4627556,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":59536,"kind":"person","name":"Ji Darren Xiaohui","position":1,"cik":"0001974687","reported_name":"Ji Darren Xiaohui","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-28T20:10:08.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":28330,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":92103,"source":{"system":"sec-edgar","filing":"0001974687-26-000006","document":"form4-09282026_040904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1974687/000197468726000006/form4-09282026_040904.xml","form_type":"4"}},{"id":4627557,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":21675,"kind":"person","name":"Sanders Corazon (Corsee) D.","position":1,"cik":"0001796536","reported_name":"Sanders Corazon (Corsee) D.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-09-28T20:10:06.000Z","date":"2026-09-24","kind":"grant","planned":false,"acquired":true,"shares":20986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs will vest on December 20, 2027, with the remainder of the RSUs vesting in 12 equal quarterly installments beginning on March 20, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":80101,"source":{"system":"sec-edgar","filing":"0001796536-26-000009","document":"form4-09282026_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000179653626000009/form4-09282026_040901.xml","form_type":"4"}},{"id":4625391,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":59534,"kind":"person","name":"Santos Carlos E","position":1,"cik":"0002097065","reported_name":"Santos Carlos E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-23T20:15:08.000Z","date":"2026-09-21","kind":"sale","planned":false,"acquired":false,"shares":5430,"price":9.14,"value":49630.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The prices sold ranged from $8.905 to $9.325 per ordinary share. The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":14246,"source":{"system":"sec-edgar","filing":"0002097065-26-000005","document":"form4-09232026_040904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2097065/000209706526000005/form4-09232026_040904.xml","form_type":"4"}},{"id":4625390,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":59534,"kind":"person","name":"Santos Carlos E","position":1,"cik":"0002097065","reported_name":"Santos Carlos E","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-23T20:15:08.000Z","date":"2026-09-21","kind":"grant","planned":false,"acquired":true,"shares":19676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."}],"balance_after":19676,"source":{"system":"sec-edgar","filing":"0002097065-26-000005","document":"form4-09232026_040904.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2097065/000209706526000005/form4-09232026_040904.xml","form_type":"4"}},{"id":4619324,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":73268,"kind":"person","name":"Zhang Ingrid","position":1,"cik":"0001964342","reported_name":"Zhang Ingrid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-09-16T20:18:52.000Z","date":"2026-09-15","kind":"grant","planned":false,"acquired":true,"shares":1131860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of September 15, 2027, September 15, 2028, and September 15, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":1131860,"source":{"system":"sec-edgar","filing":"0001964342-26-000004","document":"form4-09162026_080948.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1964342/000196434226000004/form4-09162026_080948.xml","form_type":"4"}},{"id":684494,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":22527,"kind":"person","name":"BASH ALAN","position":1,"cik":"0001908421","reported_name":"BASH ALAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CEO"}}],"security":"Ordinary Shares","published_at":"2026-08-18T20:15:15.000Z","date":"2026-08-14","kind":"grant","planned":false,"acquired":true,"shares":4908,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted share units (the \"RSUs\"). Each RSU represents a contingent right to receive one ordinary share of the Issuer upon settlement. 1/3 of the RSUs vest and becomes exercisable on each of July 27, 2027, July 27, 2028, and July 27, 2029, respectively, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":35142,"source":{"system":"sec-edgar","filing":"0001908421-26-000005","document":"form4-08182026_040805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000190842126000005/form4-08182026_040805.xml","form_type":"4"}},{"id":719684,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":33365,"kind":"person","name":"Casey Patrick John","position":1,"cik":"0002068365","reported_name":"Casey Patrick John","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-07-02T20:05:24.000Z","date":"2026-06-30","kind":"sale","planned":false,"acquired":false,"shares":6000,"price":14.8,"value":88800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents the converted sales price of ADSs of $29.60 per ADS (which is equivalent to $14.80 per ordinary share)."}],"balance_after":48604,"source":{"system":"sec-edgar","filing":"0002068365-26-000005","document":"form4-07022026_040712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000206836526000005/form4-07022026_040712.xml","form_type":"4"}},{"id":719683,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":26713,"kind":"person","name":"Huang Ying","position":1,"cik":"0001967360","reported_name":"Huang Ying","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-02T20:05:18.000Z","date":"2026-06-30","kind":"gift","planned":false,"acquired":false,"shares":3382,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents a bone fide gift to a charitable organization."}],"balance_after":238490,"source":{"system":"sec-edgar","filing":"0001967360-26-000008","document":"form4-07022026_040714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000196736026000008/form4-07022026_040714.xml","form_type":"4"}},{"id":724833,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":26713,"kind":"person","name":"Huang Ying","position":1,"cik":"0001967360","reported_name":"Huang Ying","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-30T01:53:13.000Z","date":"2026-06-25","kind":"sale","planned":false,"acquired":false,"shares":5566,"price":14.78,"value":82265.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price and represents the converted sales price of the ADSs of $29.56. The prices sold ranged from $28.13 to $29.98 per ADS (which is equivalent to $14.065 to $14.99 per ordinary share). The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":241872,"source":{"system":"sec-edgar","filing":"0001967360-26-000006","document":"form4-06302026_010610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000196736026000006/form4-06302026_010610.xml","form_type":"4"}},{"id":826806,"issuer":{"id":4033,"kind":"organization","name":"Legend Biotech Corp","symbol":"LEGN"},"owners":[{"id":26713,"kind":"person","name":"Huang Ying","position":1,"cik":"0001967360","reported_name":"Huang Ying","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-27T20:25:51.000Z","date":"2026-03-25","kind":"sale","planned":false,"acquired":false,"shares":9936,"price":8.77,"value":87138.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares of the Issuer may be represented by American Depositary Shares (\"ADSs\"). Each ADS represents two ordinary shares of the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares sold to satisfy withholding tax obligations upon the vesting of restricted share units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The prices sold ranged from $17.26 to $17.82 per ADS (which is equivalent to $8.63 to $8.91 per ordinary share). The reporting person will provide the Issuer, any security holder of the Issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":247438,"source":{"system":"sec-edgar","filing":"0001967360-26-000004","document":"form4-03272026_080347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1801198/000196736026000004/form4-03272026_080347.xml","form_type":"4"}}]}